Steve Scala
Stock Analyst at TD Cowen
(4.47)
# 1,123
Out of 5,000 analysts
403
Total ratings
62.5%
Success rate
10%
Average return
Main Sectors:
Stocks Rated by Steve Scala
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company | Reiterated: Buy | $1,250 | $1,150.99 | +8.60% | 48 | Sep 22, 2026 | |
| MRK Merck & Co. | Reiterated: Hold | $137 → $155 | $148.08 | +4.67% | 32 | Sep 22, 2026 | |
| NVS Novartis AG | Reiterated: Hold | $180 | $142.71 | +26.13% | 36 | Sep 8, 2026 | |
| ABBV AbbVie | Reiterated: Buy | $280 | $265.08 | +5.63% | 42 | Sep 4, 2026 | |
| LON: AZN AstraZeneca PLC | Reiterated: Buy | 18,007p | 12,376p | +45.50% | 9 | Aug 31, 2026 | |
| SNY Sanofi | Reiterated: Hold | $57 | $41.66 | +36.82% | 26 | Aug 31, 2026 | |
| ELAN Elanco Animal Health | Rated: Buy | $32 | $22.57 | +41.78% | 18 | Aug 25, 2026 | |
| ZTS Zoetis | Rated: Buy | $104 → $94 | $71.61 | +31.27% | 25 | Aug 25, 2026 | |
| PFE Pfizer | Reiterated: Hold | n/a | $28.18 | - | 44 | Aug 11, 2026 | |
| GSK GSK plc | Reiterated: Hold | $70 | $49.71 | +40.82% | 30 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $300 | $269.17 | +11.45% | 1 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $67 | $55.06 | +21.69% | 27 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 → $8 | $10.55 | n/a | 4 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $64 → $54 | $61.15 | n/a | 29 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $19 → $15 | $13.73 | n/a | 4 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16.80 | $8.04 | n/a | 2 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $42 | $57.65 | n/a | 4 | Dec 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.83 | n/a | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.26 | n/a | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 96.59 → CHF 109.47 | CHF 118.66 | n/a | 3 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 → $155 | $38.17 | n/a | 3 | Apr 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | 2,250p → 1,790p | 1,877p | n/a | 2 | Nov 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | CHF 367.00 | CHF 361.30 | n/a | 3 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | €41.33 → €98.00 | €72.77 | n/a | 2 | Jul 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.85 | n/a | 1 | Jun 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €67.17 → €74.57 | €132.80 | n/a | 4 | Dec 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $209 | $406.09 | n/a | 2 | Oct 3, 2017 |
Eli Lilly and Company
Sep 22, 2026
Reiterated: Buy
Price Target: $1,250
Current: $1,150.99
Upside: +8.60%
Merck & Co.
Sep 22, 2026
Reiterated: Hold
Price Target: $137 → $155
Current: $148.08
Upside: +4.67%
Novartis AG
Sep 8, 2026
Reiterated: Hold
Price Target: $180
Current: $142.71
Upside: +26.13%
AbbVie
Sep 4, 2026
Reiterated: Buy
Price Target: $280
Current: $265.08
Upside: +5.63%
AstraZeneca PLC
Aug 31, 2026
Reiterated: Buy
Price Target: 18,007p
Current: 12,376p
Upside: +45.50%
Sanofi
Aug 31, 2026
Reiterated: Hold
Price Target: $57
Current: $41.66
Upside: +36.82%
Elanco Animal Health
Aug 25, 2026
Rated: Buy
Price Target: $32
Current: $22.57
Upside: +41.78%
Zoetis
Aug 25, 2026
Rated: Buy
Price Target: $104 → $94
Current: $71.61
Upside: +31.27%
Pfizer
Aug 11, 2026
Reiterated: Hold
Price Target: n/a
Current: $28.18
Upside: -
GSK plc
Aug 3, 2026
Reiterated: Hold
Price Target: $70
Current: $49.71
Upside: +40.82%
Jul 13, 2026
Reiterated: Buy
Price Target: $300
Current: $269.17
Upside: +11.45%
Apr 23, 2026
Reiterated: Hold
Price Target: $67
Current: $55.06
Upside: +21.69%
Aug 7, 2025
Reiterated: Hold
Price Target: $9 → $8
Current: $10.55
Upside: n/a
Jul 31, 2025
Reiterated: Hold
Price Target: $64 → $54
Current: $61.15
Upside: n/a
Apr 22, 2025
Reiterated: Hold
Price Target: $19 → $15
Current: $13.73
Upside: n/a
Feb 21, 2025
Reiterated: Hold
Price Target: $16.80
Current: $8.04
Upside: n/a
Dec 24, 2024
Rated: Buy
Price Target: $42
Current: $57.65
Upside: n/a
Nov 18, 2024
Downgraded: Hold
Price Target: n/a
Current: $4.83
Upside: n/a
Nov 18, 2024
Downgraded: Hold
Price Target: n/a
Current: $1.26
Upside: n/a
Nov 11, 2024
Reiterated: Hold
Price Target: CHF 96.59 → CHF 109.47
Current: CHF 118.66
Upside: n/a
Apr 30, 2024
Reiterated: Buy
Price Target: $80 → $155
Current: $38.17
Upside: n/a
Nov 30, 2023
Reiterated: Hold
Price Target: 2,250p → 1,790p
Current: 1,877p
Upside: n/a
Nov 14, 2022
Downgraded: Hold
Price Target: CHF 367.00
Current: CHF 361.30
Upside: n/a
Jul 21, 2021
Initiated Coverage: Hold
Price Target: €41.33 → €98.00
Current: €72.77
Upside: n/a
Jun 24, 2021
Reiterated: Buy
Price Target: n/a
Current: $4.85
Upside: n/a
Dec 10, 2018
Reiterated: Hold
Price Target: €67.17 → €74.57
Current: €132.80
Upside: n/a
Oct 3, 2017
Reiterated: Buy
Price Target: $209
Current: $406.09
Upside: n/a